BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
Not yet recruiting · NCT06673459 · Registry updated 2024-11-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 3 | 2024-11-05 | NCT06673459 |
9 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | China | 36 |